Stock Taper
SCREENER COMPARE ANY 2 STOCKS
HRMY
HARMONY BIOSCIENCES HOLDINGS, INC.
NASDAQ
$39.21
▼ DOWN 1.66% (-0.66)

KEY STATISTICS

Market Cap$2.27 B
52w High$40.87
52w Low$25.52
Dividend Yield—
Frequency—
P/E12.73
Volume449.50K
Shares Out.57.89M

COMPANY

LEADERSHIP

Jeffrey Dayno
CHIEF EXECUTIVE
Jeffrey Dayno

COMPENSATION 2026

Salary$743,600
Stock Awards$1,976,520
Incentive Plan Pay$558,000
All Other Comp.$22,415
Total$7,899,535

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 19, 2020
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
293

PRICE TARGET

Target High$70.00
Target Low$34.00
Target Median$45.00
Target Consensus$48.50

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$274.55M
NOV
3
TUE

PRICE

$39.21 ▼ DOWN 1.66% (−$0.66)
$39.15$39.30$39.45$39.609:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM39.21

About Harmony Biosciences Holdings, Inc.

https://www.harmonybiosciences.com ↗

Harmony Biosciences, a commercial-stage pharma company founded in 2017 and based in Pennsylvania, develops and markets WAKIX to treat excessive daytime sleepiness in adults with narcolepsy.

INDUSTRY

Biotechnology

A PRODUCT HARMONY BIOSCIENCES HOLDINGS, INC. IS KNOWN FOR

WAKIX® (pitolisant)
WAKIX® (pitolisant)

WAKIX® is an FDA-approved, non-scheduled medication by Harmony Biosciences that treats excessive daytime sleepiness and cataplexy in narcolepsy patients, serving as the company's primary revenue driver with a novel mechanism enhancing brain histam...

COMPETITORS

COMPETITOR
ALKS COMPARE
AXSM COMPARE
JAZZ COMPARE
TAK COMPARE

Revenue by Geography

MapREGIONQ1-2023Q2-2023Q3-2023Q4-2023
UNITED STATES$500M $500M $500M $0 ▼

ETFS HOLDING THIS STOCK

ETFS HOLDING
239
LISTED HERE
26
RANKED BY POSITION SIZE
AVUV
0.31% · 2.4M
XUU.TO
0.00% · 2.4M
AFTY
1.44% · 1.9M
VTI
0.00% · 1.6M
FESM
0.41% · 673.2K
PJP
3.27% · 439.4K
SPSM
0.09% · 374.1K
DFAT
0.08% · 285.3K
JSMD
0.83% · 226.4K
SCHA
0.03% · 188.9K
SFLO
0.78% · 156.3K
PSC
0.17% · 121.0K
FYX
0.28% · 97.3K
LSVD
0.37% · 62.0K
EC
ECML
1.63% · 54.7K
GSSC
0.20% · 54.5K
SIXS
1.46% · 53.1K
BBP
1.42% · 42.5K
XRS2.DE
0.06% · 41.3K
TQSM.TO
0.21% · 40.3K
EES
0.20% · 37.0K
CGV
1.01% · 34.4K
FSCC
0.37% · 32.6K
DSMC
0.65% · 24.1K
RSSL
0.06% · 21.6K
ROSC
1.20% · 16.3K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
64.26%
HOLDERS
417
TOP 12 OF 417 · RANKED BY POSITION SIZE
Blackrock, Inc.
7.1M sh · $258.58M
Blackrock Inc.
5.8M sh · $176.05M
Vanguard Group Inc
5.1M sh · $140.48M
Fmr LLC
3.8M sh · $106.02M
American Century Companies Inc
2.5M sh · $92.46M
Dimensional Fund Advisors LP
2.4M sh · $87.14M
Lsv Asset Management
2.1M sh · $75.05M
Sg Americas Securities, LLC
2.0M sh · $56.53M
State Street Corp
1.9M sh · $67.7M
Armistice Capital, LLC
1.6M sh · $45.49M
Geode Capital Management, LLC
1.4M sh · $52.53M
Arrowstreet Capital, Limited Partnership
1.4M sh · $38.71M

RATINGS SNAPSHOT

Overall rating: A

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity5
Return On Assets5
Debt To Equity3
Price To Earnings2
Price To Book3
Overall Score4

INSIDER TRADES

★
OFFICER: INT PRINCIAL FINANCIAL OFFICER
Mollichella Stephen M.
— · 5.9K shares
2026-07-16
★
OFFICER: INT PRINCIAL FINANCIAL OFFICER
Mollichella Stephen M.
— · 7.0K shares
2026-07-16
★
OFFICER: INT PRINCIAL FINANCIAL OFFICER
Mollichella Stephen M.
— · —
2026-07-16
★
OFFICER: INT PRINCIAL FINANCIAL OFFICER
Mollichella Stephen M.
— · 8.5K shares
2026-07-16

MOST RECENT ANALYST GRADES

GRADE SUMMARY
HOLD 2
BUY 2
OUTPERFORM 1
NEUTRAL 1
UNDERPERFORM 1
7 GRADES IN THE LAST 12 MONTHS
Truist Securities HOLD Needham BUY Mizuho OUTPERFORM HC Wainwright & Co. BUY Deutsche Bank HOLD UBS NEUTRAL B of A Securities UNDERPERFORM

SECTORS PEERS

PEERPRICE
ABCL$11.35COMPARE
CLDX$39.12COMPARE
VERA$34.19COMPARE
BHVN$15.41COMPARE
NUVB$6.66COMPARE
AUPH$16.29COMPARE
IMCR$36.62COMPARE
MNKD$3.95COMPARE